In the Angara region, flu vaccination continues, but only half of more than 350 thousand doses allocated for risk groups have been used. Doctors warn this year the illness may be especially severe, and at least a quarter of the population needs vaccination for stability in the region. Why residents are not rushing to clinics and how the current Grippol vaccine differs is in the report.
Influenza epidemics begin in the autumn-winter period in Southeast Asia and quickly spread throughout the world. In Russia, more than four million cases of influenza are officially recorded every year... According to forecasts, this year the flu will occur in an especially severe form: there is a high likelihood of complications and fatalities.As of today, from the vaccine received, more than 350 thousand doses have been allocated for the Angara region for the at-risk group, and half have been used. The "at-risk group" includes citizens aged 60 and over, children, medical workers, education workers, and service industry workers. The reason for the low turnout, specialists believe, is citizens' distrust of domestic medicines. Although, doctors add, this year the "Grippol" vaccine is more purified, with a changed strain composition. Rospotrebnadzor reports: in order to achieve a stable situation with influenza incidence and guaranteed protection of the population, it is necessary to vaccinate a quarter of the region's population. This means that at least another 200 thousand people must go to the polyclinics at their place of residence and get vaccinated.